BUSPIRONE AND 1-(2-PYRIMIDINYL)-PIPERAZINE ATTENUATE XYLAZINE-INDUCED ANTINOCICEPTION IN THE MOUSE

被引:0
|
作者
CAO, BJ
LI, WP
机构
[1] Department of Pharmacology, Hunan Institute of Pharmaceutical Industry, Changsha
关键词
D O I
10.1111/j.2042-7158.1994.tb05720.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The effects of subcutaneous pretreatment with buspirone and its major metabolite 1-(2-pyrimidinyl)-piperazine (1-PP) on the antinociceptive effect of xylazine were examined using the mouse acetic acid assay. Both buspirone and 1-PP dose-dependently attenuated the antinociceptive action of subcutaneously administered xylazine (0.8 mg kg(-1)), with ED50 values of 7.3 mg kg(-1) for buspirone and 3.4 mg kg(-1) for 1-PP. Pretreatment with either buspirone (8 mg kg(-1))or 1-PP (4 mg kg(-1)) increased the antinociceptive ED50 of xylazine 3-4-fold. These data support the involvement of alpha(2)-adrenoceptor and 1-PP in the pharmacological activity of buspirone.
引用
收藏
页码:931 / 932
页数:2
相关论文
共 50 条
  • [31] SIMULTANEOUS HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ANALYSIS OF BUSPIRONE AND ITS METABOLITE 1-(2-PYRIMIDINYL)-PIPERAZINE IN PLASMA USING ELECTROCHEMICAL DETECTION
    BETTO, P
    MENEGUZ, A
    RICCIARELLO, G
    PICHINI, S
    JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1992, 575 (01): : 117 - 121
  • [32] Gepirone and 1-(2-pyrimidinyl)-piperazine in vitro: human cytochromes mediating transformation and cytochrome inhibitory effects
    L. L. von Moltke
    D. J. Greenblatt
    J. M. Grassi
    B. W. Granda
    S. M. Fogelman
    J. S. Harmatz
    S. J. Kramer
    L. F. Fabre
    R. I. Shader
    Psychopharmacology, 1998, 140 : 293 - 299
  • [33] KINETICS, BRAIN UPTAKE AND RECEPTOR-BINDING OF TANDOSPIRONE AND ITS METABOLITE 1-(2-PYRIMIDINYL)-PIPERAZINE
    MILLER, LG
    THOMPSON, ML
    BYRNES, JJ
    GREENBLATT, DJ
    SHEMER, A
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1992, 12 (05) : 341 - 345
  • [34] 1-(2-PYRIMIDINYL)PIPERAZINE ANTAGONIZES GABA-ACTIVATED CURRENTS IN CULTURED SPINAL NEURONS OF THE RAT
    SMITH, SM
    HUGHES, D
    BRAIN RESEARCH, 1989, 493 (02) : 366 - 367
  • [35] Gepirone and 1-(2-pyrimidinyl)-piperazine in vitro: human cytochromes mediating transformation and cytochrome inhibitory effects
    von Moltke, LL
    Greenblatt, DJ
    Grassi, JM
    Granda, BW
    Fogelman, SM
    Harmatz, JS
    Kramer, SJ
    Fabre, LF
    Shader, RI
    PSYCHOPHARMACOLOGY, 1998, 140 (03) : 293 - 299
  • [36] SIMULTANEOUS DETERMINATION OF BUSPIRONE, GEPIRONE, IPSAPIRONE AND THEIR COMMON METABOLITE 1-(2-PYRIMIDINYL)PIPERAZINE IN RAT PLASMA AND BRAIN BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY
    BIANCHI, G
    CACCIA, S
    JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1988, 431 (02): : 477 - 480
  • [37] EVALUATION OF THE ALPHA(2)-ADRENOCEPTOR BLOCKING PROPERTIES OF BUSPIRONE AND IPSAPIRONE IN HEALTHY-SUBJECTS - RELATIONSHIP WITH THE PLASMA-CONCENTRATION OF THE COMMON METABOLITE 1-(2-PYRIMIDINYL)-PIPERAZINE
    BERLIN, I
    CHALON, S
    PAYAN, C
    SCHOLLNHAMMER, G
    CESSELIN, F
    VAROQUAUX, O
    PUECH, AJ
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 39 (03) : 243 - 249
  • [38] ANTAGONIST PROPERTIES OF 1-(2-PYRIMIDINYL)PIPERAZINE AT PRESYNAPTIC ALPHA-2-ADRENOCEPTORS IN THE RAT-BRAIN
    GOBBI, M
    FRITTOLI, E
    MENNINI, T
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 180 (01) : 183 - 186
  • [39] Determination of buspirone and its metabolite 1-(2-pyrimidinyl)-piperaxine in human plasma by liquid chromatography tandem mass spectrometry
    Green, R
    Houghton, R
    Jacobs, S
    CHROMATOGRAPHIA, 2004, 59 (Suppl 2) : S197 - S201
  • [40] QUANTITATIVE-ANALYSIS OF 1-(2-PYRIMIDINYL)PIPERAZINE IN PLASMA BY CAPILLARY GAS-CHROMATOGRAPHY MASS-SPECTROMETRY
    KERNS, EH
    BULLEN, WW
    GAMMANS, RE
    JOURNAL OF CHROMATOGRAPHY, 1986, 377 : 195 - 203